Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Normative Hand Grip Strength Values in Swedish Male and Female Ice Hockey Players Across Competitive Levels

22 de mayo de 2026 actualizado por: Daniel Muder, Dalarna County Council, Sweden

This study measures hand grip strength in male and female ice hockey players across different Swedish leagues to create reference (normative) values for adult players.

Hand grip strength is a simple test of how strongly a person can squeeze with their hand. Although it seems basic, it reflects overall upper-body strength and is widely used in both sports science and healthcare.

In this project, players from different levels of ice hockey (including professional men's and women's leagues, junior players, and recreational players if available) will have their grip strength measured using a standardized hand dynamometer. Measurements will be taken in a consistent way across all participating clubs.

The main goal is to build a reference database showing what "normal" grip strength looks like in ice hockey players depending on sex, league level, and playing position. This can help coaches, medical staff, and researchers better understand strength profiles in hockey athletes, support training and rehabilitation decisions, and provide benchmarks for future studies.

No treatment or intervention is given as part of the study.

Descripción general del estudio

Descripción detallada

This is a cross-sectional, descriptive, multi-league study designed to establish normative values for maximal isometric hand grip strength in adult Swedish ice hockey players.

Hand grip strength will be used as a standardized, low-cost proxy measure of upper-body muscular strength and general functional capacity. Although grip strength is widely used in clinical and sports science settings and has demonstrated good reliability when measured using standardized protocols, there is currently a lack of comprehensive normative data for adult ice hockey players. Existing literature is largely limited to youth cohorts or general athletic "combine"-type populations, with insufficient stratification for adult competitive ice hockey across sexes, league levels, and playing positions.

This study will include male and female players from multiple competitive levels in Swedish ice hockey, including professional leagues (SHL and SDHL), second-tier leagues (HockeyAllsvenskan and Women's Allsvenskan where feasible), junior elite levels (U18/U20), and potentially recreational adult players. Participants will be recruited through participating clubs during the pre-season or early competitive season period.

Grip strength will be measured using a standardized hand dynamometer according to a unified protocol aligned with established clinical measurement guidelines (including standardized positioning, device calibration, and repeated trials per hand). Both dominant and non-dominant hand grip strength will be recorded, and mean values will be used for analysis. To reduce inter-tester variability, participating sites will be instructed to follow a harmonized measurement protocol.

In addition to grip strength, basic demographic and anthropometric data will be collected, including age, sex, playing position (forward/defense), playing experience, height, and body mass. Where available, supplementary body composition data from club testing routines may also be included to allow exploratory analyses of strength relative to body size.

The primary purpose of the study is descriptive: to generate normative reference values (including percentiles) for grip strength in adult ice hockey players, stratified by sex, league level, and playing position. Secondary analyses will explore associations between grip strength and anthropometric and demographic variables.

This study does not include any intervention or experimental treatment. All measurements are non-invasive and performed during routine testing environments within clubs. The results are intended to support strength and conditioning practice, clinical assessment in sports medicine, and future research on performance, injury risk, and rehabilitation in ice hockey.

Tipo de estudio

De observación

Inscripción (Estimado)

800

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Daniel Muder, MD, PhD
  • Número de teléfono: +46722027596
  • Correo electrónico: danielmuder@email.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

Adult male and female ice hockey players recruited from Swedish ice hockey clubs across multiple competitive levels, including professional (SHL and SDHL), second-tier (HockeyAllsvenskan and Women's Allsvenskan where available), junior elite (U18/U20), and selected recreational teams. Participants are drawn from active club rosters during the pre-season or early competitive season period. Recruitment is conducted in collaboration with participating clubs and their medical or strength and conditioning staff. The population represents a broad sample of Swedish ice hockey players across sex, age, and competitive level.

Descripción

Inclusion Criteria:

  • Adult male or female ice hockey players.
  • Registered and actively participating in a Swedish ice hockey club during the current season.
  • Participation in one of the included competitive levels: professional, semi-professional, junior elite, or recreational leagues in Sweden.
  • Able to perform maximal hand grip strength testing. Provides written informed consent.

Exclusion Criteria:

  • Current acute injury of the upper extremity (hand, wrist, forearm, or elbow) that prevents safe or valid grip strength testing.
  • Any medical condition that contraindicates maximal effort testing, as determined by team medical staff or study personnel.
  • Refusal or inability to provide informed consent.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Ice Hockey Players
Adult male and female ice hockey players from multiple competitive levels in Sweden, including professional, semi-professional, junior elite, and recreational players. Participants undergo a single standardized measurement of hand grip strength.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Maximal Hand Grip Strength
Periodo de tiempo: Baseline.
Maximal isometric hand grip strength measured in kilograms using a standardized hand dynamometer in adult male and female ice hockey players. Measurements will be performed for both dominant and non-dominant hands using a standardized protocol, and mean maximal value will be used for analysis.
Baseline.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Anthropometric Characteristics
Periodo de tiempo: Baseline.
Height (cm), body mass (kg), and body composition (if available) of adult male and female ice hockey players.
Baseline.
Demographic and Playing Characteristics
Periodo de tiempo: Baseline.
Age, sex, playing position (forward/defense), league level, dominant hand, and years of playing experience in ice hockey.
Baseline.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Daniel Muder, MD, PhD, Centre for Clinical Research Dalarna, Uppsala University, Sweden

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

31 de diciembre de 2026

Finalización del estudio (Estimado)

31 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

23 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de abril de 2026

Publicado por primera vez (Actual)

5 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

27 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

22 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2026-02210-01B

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

Marco de tiempo para compartir IPD

From the publication of the protocol and for 10 years thereafter.

Criterios de acceso compartido de IPD

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir